LEO Pharma Presents Late-Breaking Phase 3 Delgocitinib Cream Data in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE) BioSpace Source link
Dupixent® (dupilumab) Late-Breaking Data at AAD Show Significant … GlobeNewswire Source link